MedicaidPrior AuthMedium impact
Gamifant® (emapalumab-lzsg) (Revised)
Humana·OH · Hematology, Oncology, Pediatrics·Medicaid
We identified it
Jul 1, 2026
Summary
This is a revised Prior Authorization policy for Gamifant® (emapalumab-lzsg), a specialty biologic medication, affecting Medicaid coverage for Ohio members. The policy update requires immediate review to determine what authorization requirements have changed from the previous version.
Action Required
Immediately: Billing team must obtain the full policy document (not summary-only) to identify specific prior authorization requirements, affected HCPCS codes (likely J-codes for emapalumab), and any changes from the previous policy version. Compare revised requirements against current billing workflows and EMR templates. Contact Humana Ohio Medicaid directly at the source URL to confirm effective date and implementation deadline. Update prior authorization procedures in billing system once full policy details are available. Do not process claims for Gamifant® without confirming current authorization requirements, as claims submitted under outdated criteria will be denied.